Mesoblast LimitedASX: MSB

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Mesoblast Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/quarterly-activitiesappendix-4c-cash-flow-report-523

Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call

ACTIVITY REPORT FOR QUARTER ENDED SEPTEMBER 30, 2026 (APPENDIX 4C) New York, USA: October 28 and Melbourne, Australia: October 29, 2026: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today provided its activity report for the...

View Attachment

6ix is reading this filing.

Mesoblast Limited on 6ix

Earlier from Mesoblast

All Mesoblast news releases